IAAG
MRNA icon

Innovative Asset Advisors Group’s Moderna MRNA Stock Holding History

Innovative Asset Advisors Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26
Closed -$1.32K – 736
2026
Q1 		$1.32K Buy
+26
New +$1.21K ﹤0.01% 950

Other funds holding MRNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Innovative Asset Advisors Group's MRNA Position: Q2 2026 in Review

Innovative Asset Advisors Group sold out of Moderna (MRNA) in Q2 2026, closing a stake of 26 shares — an estimated $1.32K sold.

Innovative Asset Advisors Group first reported a position in MRNA in Q1 2026 and held it in 1 quarter. The position peaked at $1.32K in Q1 2026. 730 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Innovative Asset Advisors Group reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Innovative Asset Advisors Group sold 26 Moderna shares in Q2 2026, an estimated $1.32K.
  • Innovative Asset Advisors Group first reported a position in Moderna in Q1 2026 and held it in 1 quarter.
  • Innovative Asset Advisors Group's Moderna position peaked at $1.32K in Q1 2026.
  • 730 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Innovative Asset Advisors Group's 13F filing for Q2 2026, filed 5 Aug 2026.